NorthCrest Asset Manangement’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
MG
OAM
NorthCrest Asset Manangement's NVO Position: Q2 2026 in Review
NorthCrest Asset Manangement opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,719 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #814 among its holdings. This is a return to the name: NorthCrest Asset Manangement previously reported a position in NVO as recently as Q4 2025.
NorthCrest Asset Manangement first reported a position in NVO in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.55M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- NorthCrest Asset Manangement held 4,719 shares of Novo Nordisk worth $231K as of Q2 2026.
- Novo Nordisk was a new NorthCrest Asset Manangement position in Q2 2026.
- Novo Nordisk made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #814 holding.
- NorthCrest Asset Manangement first reported a position in Novo Nordisk in Q1 2022 and has held it in 17 quarters since.
- NorthCrest Asset Manangement's Novo Nordisk position peaked at $1.55M in Q2 2024.
- 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.